- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | BioHarvest Sciences sets share repurchase plan | 2 | Seeking Alpha | ||
| Di | BioHarvest Sciences Inc.: BioHarvest Sciences Announces Share Repurchase Program | 203 | Newsfile | Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 29, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (TASE: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a Botanical... ► Artikel lesen | |
| 15.09. | BioHarvest Sciences Inc.: BioHarvest Advances Botanical Synthesis Leadership as VINIA Daily Chews Unlock More Value from Its First Consumer Product | 229 | Newsfile | Single-dose VINIA Daily Chews broaden demographics and usage occasions while demonstrating the commercial versatility of Botanical SynthesisFormat expansion shows how BioHarvest can help CDMO partners... ► Artikel lesen | |
| 14.09. | BIOHARVEST SCIENCES INC. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 14.09. | BioHarvest Sciences Inc.: BioHarvest Sciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference | 241 | Newsfile | Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 14, 2026) - BioHarvest Sciences Inc (NASDAQ: BHST) (TASE: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and... ► Artikel lesen | |
| BIOHARVEST SCIENCES Aktie jetzt für 0€ handeln | |||||
| 03.09. | BIOHARVEST SCIENCES INC. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 03.09. | BioHarvest Sciences to dual-list shares on Tel Aviv exchange | 1 | Investing.com | ||
| 26.08. | BioHarvest Sciences stellt auf Investorenkonferenz Skalierungspläne für Pflanzenzell-Plattform vor | 3 | Investing.com Deutsch | ||
| 12.08. | BioHarvest: Wachstum durch industrielle Pflanzenzell-Technologie | 4 | Investing.com Deutsch | ||
| 11.08. | BioHarvest Sciences Inc.: BioHarvest Reports Second Quarter 2026 Financial Results and Provides Business Update | 1.152 | Newsfile | Secured first ever CDMO Manufacturing Agreement supporting planned 20-ton commercial production program over two years for rare botanical fragrance, that BioHarvest expects to drive profitable growth... ► Artikel lesen | |
| 11.08. | BioHarvest Sciences GAAP EPS of -$0.17 misses by $0.05, revenue of $8.84M misses by $0.61M | 4 | Seeking Alpha | ||
| 11.08. | BioHarvest sichert sich Millionen-Auftrag für seltene Duftstoffe | 2 | Investing.com Deutsch | ||
| 11.08. | BioHarvest secures fragrance manufacturing deal worth $20-30M | 4 | Investing.com | ||
| 11.08. | BioHarvest Sciences Inc.: BioHarvest Secures 20-Ton Manufacturing and Supply Agreement for Rare Botanical Luxury Fragrance | 298 | Newsfile | Exclusive agreement through 2027 and 2028 is estimated to generate $20-$30 million in revenuePositions BioHarvest in sustainable rare luxury fragrance manufacturing BioHarvest to target additional... ► Artikel lesen | |
| 29.07. | BioHarvest Sciences Inc.: BioHarvest Sciences to Present at the Canaccord Genuity 46th Annual Growth Conference | 331 | Newsfile | Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - July 29, 2026) - BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable... ► Artikel lesen | |
| 28.07. | BIOHARVEST SCIENCES INC. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 28.07. | BioHarvest Sciences Inc.: BioHarvest Sciences to Report Second Quarter 2026 Financial Results on August 11, 2026 | 248 | Newsfile | Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - July 28, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a leader in Botanical Synthesis... ► Artikel lesen | |
| 15.07. | BIOHARVEST SCIENCES INC. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 15.07. | BioHarvest receives $1.4M grant for AI research platform | 2 | Investing.com | ||
| 15.07. | BioHarvest erhält 1,4 Mio. USD für KI-gestützte Forschungsplattform | 4 | Investing.com Deutsch |
1 2 3 4 Weiter >>
61 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 45,400 | -5,32 % | 90 Milliarden US-Dollar bis 2030: Wie Bayer, Mesoblast und NurExone regenerative Medizin unterschiedlich entwickeln | ||
| PFIZER | 24,980 | -0,14 % | Eli Lilly und Novo Nordisk bekommen neue Konkurrenz - warum der 100-Milliarden-Dollar-Markt immer mehr Biotech-Unternehmen anzieht | ||
| MERCK KGAA | 134,45 | -2,64 % | Merck Aktie | Wichtige Durchschnittslinien durchbrochen | Analyse | ||
| AURORA CANNABIS | 3,428 | -1,61 % | Aurora Cannabis: Beschwerde bringt den Deal ins Wanken | ||
| CANOPY GROWTH | 0,783 | -0,58 % | Canopy Growth Corporation: Canopy Growth Appoints Sebastian Blöte as Country Manager for Germany | Mr. Blöte's appointment strengthens Canopy Growth's commercial leadership as it drives growth across its European medical cannabis businessCanopy Growth Corporation ("Canopy Growth", "our", "we" or... ► Artikel lesen | |
| TILRAY BRANDS | 3,215 | +1,42 % | Tilray Brands, Inc.: BrewDog Builds Momentum for Next Growth Chapter with Expanded Senior Leadership Team | New appointments strengthen marketing, hospitality, category, and international commercial leadership as BrewDog advances long-term growth under Tilray BrandsELLON, Scotland and LONDON, Sept. 28, 2026... ► Artikel lesen | |
| BRISTOL-MYERS SQUIBB | 54,51 | -0,29 % | Bristol-Myers Squibb Company: Care Within Reach: How the Bristol Myers Squibb Foundation Is Strengthening Health Systems Across Africa | Originally published by the Bristol Myers Squibb Foundation NORTHAMPTON, MA / ACCESS Newswire / September 28, 2026 / Francis Kwoba is a 68-year-old retired policeman from Bungoma County, Kenya. During... ► Artikel lesen | |
| DERMAPHARM | 38,450 | -1,91 % | JEFFERIES stuft Dermapharm auf 'Hold' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Dermapharm nach einem Treffen mit dem Finanzchef Christof Dreibholz mit einem Kursziel von 44 Euro auf "Hold" belassen.... ► Artikel lesen | |
| CRONOS GROUP | 2,816 | -1,61 % | Cronos Group Inc.: Cronos Group Reports 2026 Second Quarter Results | Organically achieved record net revenue, gross profit, and Adjusted EBITDA while reducing share count Net revenue in Q2 2026 increased by 51% year-over-year on an organic, constant-currency basis... ► Artikel lesen | |
| DIGICANN VENTURES | 0,005 | -47,37 % | XFRA VY3: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| INCYTE | 104,90 | +0,62 % | Biotech-Aktien vor dem Datentest: Morgan Stanley setzt auf Biotech-Moonshots: Argenx, Arrowhead, Incyte und Sana vor wichtigen Datentests | Vier Biotech-Unternehmen stehen vor wichtigen klinischen Bewährungsproben. Morgan Stanley sieht bei Argenx, Arrowhead, Incyte und Sana Programme mit hohem wirtschaftlichem Potenzial, deren weiterer... ► Artikel lesen | |
| EYEPOINT | 2,900 | +0,69 % | XFRA PV3B: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 0,910 | +4,12 % | ORGANIGRAM GLOBAL INC. - 6-K, Report of foreign issuer | ||
| GREEN THUMB INDUSTRIES | 5,940 | -1,49 % | Green Thumb Industries Reports Second Quarter 2026 Results | CHICAGO and VANCOUVER, British Columbia, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. ("Green Thumb" or the "Company") (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer... ► Artikel lesen | |
| SNDL | 1,105 | 0,00 % | Immortal Dragons: Sundial Initiative Advisor Boyang Wang Sponsors Nakauchi Lab's Work on "Bodyoids" | SINGAPORE, SG / ACCESS Newswire / July 30, 2026 / Boyang Wang, advisor to the Sundial Initiative and founder and CEO of the longevity fund Immortal Dragons, has sponsored the Nakauchi Lab, led by stem... ► Artikel lesen |
Das Unternehmen BIOHARVEST SCIENCES INC kann der Branche Pharma zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,100 (-8,00 %) liegt der Kurs bei 1,150 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BIOHARVEST SCIENCES INC finden Sie auf Wallstreet Online.